FDA Drug Recalls

Recalls / Class III

Class IIID-0995-2019

Product

Esomeprazole Magnesium Delayed-Release Capsules USP, 40mg*, a) 90-count bottle (NDC 43598-510-90) b) 1000 count bottle (NDC 43598-510-10), Rx only, Mfd By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 INDIA.

Brand name
Esomeprazole Magnesium
Generic name
Esomeprazole Magnesium
Active ingredient
Esomeprazole Magnesium
Route
Oral
NDCs
43598-509, 43598-510
FDA application
ANDA078279
Affected lot / code info
Lot #: a) C800589, Exp 5/2019; C706058, Exp 03/2019 Lot #: b) C704873 Exp 02/2019; C800951, C800953 Exp 06/2019.

Why it was recalled

Discoloration: Esomeprazole Magnesium DR Capsules (40mg) may contain brown pellets.

Recalling firm

Firm
Dr. Reddy's Laboratories, Inc.
Manufacturer
Dr. Reddy's Laboratories Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
107 College Rd E, N/A, Princeton, New Jersey 08540-6623

Distribution

Quantity
40,592, 90 and 1,000 count bottles
Distribution pattern
Distributed Nationwide in the USA

Timeline

Recall initiated
2019-02-06
FDA classified
2019-03-12
Posted by FDA
2019-02-20
Terminated
2021-01-26
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0995-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Esomeprazole Magnesium · FDA Drug Recalls